Macular Pigment and Lutein Supplementation in ABCA4-Associated Retinal Degenerations
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
PURPOSE: To determine macular pigment (MP) optical density (OD) in patients with ABCA4-associated retinal degenerations (ABCA4-RD) and the response of MP and vision to supplementation with lutein. METHODS: Patients with Stargardt disease or cone-rod dystrophy and known or suspected disease-causing mutations in the ABCA4 gene were included. All patients had foveal fixation. MPOD profiles were measured with heterochromatic flicker photometry. Serum carotenoids, visual acuity, foveal sensitivity, and retinal thickness were quantified. Changes in MPOD and central vision were determined in a subset of patients receiving oral supplementation with lutein for 6 months. RESULTS: MPOD in patients ranged from normal to markedly abnormal. As a group, patients with ABCA4-RD had reduced foveal MPOD, and there was a strong correlation with retinal thickness. Average foveal tissue concentration of MP, estimated by dividing MPOD by retinal thickness, was normal in patients, whereas serum concentration of lutein and zeaxanthin was significantly lower than normal. After oral lutein supplementation for 6 months, 91% of the patients showed significant increases in serum lutein, and 63% of the patients' eyes showed a significant augmentation in MPOD. The retinal responders tended to be female and to have lower serum lutein and zeaxanthin, lower MPOD, and greater retinal thickness at baseline. Responding eyes had significantly lower baseline MP concentration than did nonresponding eyes. Central vision was unchanged after the period of supplementation. CONCLUSIONS: MP is strongly affected by the stage of ABCA4 disease leading to abnormal foveal architecture. MP could be augmented by supplemental lutein in some patients. There was no change in central vision after 6 months of lutein supplementation. Long-term influences of this supplement on the natural history of these macular degenerations require further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435
Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881 · cited 4×
“Phagocytosis of the shed POS by adjacent retinal pigment epithelial (RPE) cells in ABCA4-deficient retinas results in excessive intracellular accumulation of lipofuscin, an aggregate of lipids, proteins, and fluorescent retinoids, including cytotoxic bis-retinoid A2E derived from the trapped A2PE.3,15 In extramacular…”
BackgroundResultInfluentialB IOLOGIC M ECHANISMS OF THE P ROTECTIVE R OLE OF L UTEIN AND Z EAXANTHIN IN THE E YE
Krinsky, N. I., Landrum, J. T., & Bone, R. A. (2003) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073307 · Cited by 779
RPE lipofuscin and its role in retinal pathobiology
Sparrow, J. R., & Boulton, M. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.01.007 · Cited by 644
Sun, H., Molday, R. S., & Nathans, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8269 · Cited by 353
A2E, a byproduct of the visual cycle
Sparrow, J. R., Fishkin, N., Zhou, J., Cai, B., Jang, Y. P., Krane, S., Itagaki, Y., & Nakanishi, K. (2003) · Vision Research · doi:10.1016/s0042-6989(03)00475-9 · Cited by 318 · cited 2×
“Pathogenesis of human ABCA4 disease involves a dramatic increase in A2-PE and A2E.(3,13,14) Consistent with earlier reports,(70,71) we found foveal MPOD to be significantly lower than normal in these patients.”
ResultABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy
Molday, L. L., Rabin, A. R., & Molday, R. S. (2000) · Nature Genetics · doi:10.1038/77004 · Cited by 269
Beharry, S., Zhong, M., & Molday, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405216200 · Cited by 174
Bahrami, H., Melia, M., & Dagnelie, G. (2006) · BMC Ophthalmology · doi:10.1186/1471-2415-6-23 · Cited by 88
Papermaster, D. S., Reilly, P., & Schneider, B. G. (1982) · Vision Research · doi:10.1016/0042-6989(82)90204-8 · Cited by 70
Cited by
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options
Tanna, P., Strauss, R. W., Fujinami, K., & Michaelides, M. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-308823 · Cited by 370
ABCA4 disease progression and a proposed strategy for gene therapy
Cideciyan, A. V., Swider, M., Aleman, T. S., Tsybovsky, Y., Schwartz, S. B., Windsor, E. A. M., Roman, A. J., Sumaroka, A., Steinberg, J. D., Jacobson, S. G., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn421 · Cited by 186
Self-citationBrito-García, N., del Pino-Sedeño, T., Trujillo-Martín, M. M., Coco, R. M., Rodríguez de la Rúa, E., del Cura-González, I., & Serrano-Aguilar, P. (2017) · Eye · doi:10.1038/eye.2016.286 · Cited by 26
Sofi, F., Sodi, A., Franco, F., Murro, V., Biagini, D., Miele, A., Abbruzzese, G., Mucciolo, D. P., Virgili, G., Menchini, U., et al. (2016) · BMC Ophthalmology · doi:10.1186/s12886-016-0187-3 · Cited by 24
“Moreover, in such patients a supplementation with lutein, a retinal carotenoid, increases macula pigment density but it seems not to be associated with changes in central vision over a 6 months-follow up period [7].”
Background
Metadata
- Authors
- Aleman, T. S., Cideciyan, A. V., Windsor, E. A. M., Schwartz, S. B., Swider, M., Chico, J. D., Sumaroka, A., Pantelyat, A. Y., Duncan, K. G., Gardner, L. M., Emmons, J. M., Steinberg, J. D., Stone, E. M., & Jacobson, S. G.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2007-03-01
- Volume
- 48
- Issue
- 3
- Pages
- 1319
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2005172068
- Cited by
- 70
- References
- 10
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.